Proctor Elizabeth A, Kota Pradeep, Aleksandrov Andrei A, He Lihua, Riordan John R, Dokholyan Nikolay V
Curriculum in Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC 27599, USA ; Program in Molecular and Cellular Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
Program in Molecular and Cellular Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA ; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
Chem Sci. 2015 Feb;6(2):1237-1246. doi: 10.1039/C4SC01320D.
Many cellular functions necessary for life are tightly regulated by protein allosteric conformational change, and correlated dynamics between protein regions has been found to contribute to the function of proteins not previously considered allosteric. The ability to map and control such dynamic coupling would thus create opportunities for the extension of current therapeutic design strategy. Here, we present an approach to determine the networks of residues involved in the transfer of correlated motion across a protein, and apply our approach to rescue disease-causative mutant cystic fibrosis transmembrane regulator (CFTR) ion channels, ΔF508 and ΔI507, which together constitute over 90% of cystic fibrosis cases. We show that these mutations perturb dynamic coupling within the first nucleotide-binding domain (NBD1), and uncover a critical residue that mediates trans-domain coupled dynamics. By rationally designing a mutation to this residue, we improve aberrant dynamics of mutant CFTR as well as enhance surface expression and function of both mutants, demonstrating the rescue of a disease mutation by rational correction of aberrant protein dynamics.
许多生命所必需的细胞功能都受到蛋白质变构构象变化的严格调控,并且已发现蛋白质区域之间的相关动力学有助于那些以前不被认为具有变构作用的蛋白质发挥功能。因此,绘制和控制这种动态耦合的能力将为扩展当前的治疗设计策略创造机会。在这里,我们提出了一种方法来确定参与蛋白质中相关运动传递的残基网络,并将我们的方法应用于拯救导致疾病的突变型囊性纤维化跨膜调节因子(CFTR)离子通道,即ΔF508和ΔI507,它们共同构成了超过90%的囊性纤维化病例。我们表明,这些突变扰乱了第一个核苷酸结合结构域(NBD1)内的动态耦合,并发现了一个介导跨结构域耦合动力学的关键残基。通过合理设计针对该残基的突变,我们改善了突变型CFTR的异常动力学,同时增强了两种突变体的表面表达和功能,证明了通过合理纠正异常蛋白质动力学来拯救疾病突变。